Cardiology Prevention in Systemic Lupus Erythematosus (SLE)

Withdrawn before enrolling · Not applicable

Conditions studied: Systemic Lupus Erythematosus

In brief

We propose a feasibility study of aggressive CV risk factor management directed by preventive cardiology compared to usual care. We will determine: 1) the efficacy of a preventive cardiology program compared to usual care in slowing the progression of carotid IMT and plaque, and 2) the effect of a preventive cardiology program versus usual care at achieving CV risk factor target goals. We hypothesize Lupus patients randomized to the preventive cardiology program will have less cardiovascular progression over two years than those lupus patients who are given standard care for cardiovascular risk, defined by carotid intima-media thickness and plaque.

Key facts

Study ID
NCT00610805
Run by
University of Pittsburgh
People needed
0
Starts
2009-11-01
Expected to finish
2009-11-01
Last updated by the study team
2016-01-15

Who can join

Age: 19 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.